Kalorama's new report on global advanced patient monitoring market

According to Kalorama Information, the global advanced patient monitoring market is currently worth about $31.4 billion, inclusive of devices, peripherals, software, packaged services and other applications. The market has benefited from the demand to move to a more wireless and streamlined operation both within major health facilities and in the home treatment markets. Kalorama's report, Advanced Remote Patient Monitoring Systems, in its eighth edition, is a comprehensive study on the patient monitoring industry, including patient monitoring equipment and devices that have advanced features.

"Cost savings are the major driver of sales, but the demand to integrate data into an EMR has also helped fuel purchases of new PM systems," said Bruce Carlson, Publisher of Kalorama Information. "There is also an increasing trend to upgrade to ambulatory and hand-held devices."

Advanced patient monitoring systems are focused on utilizing the technologies recently introduced to the healthcare field. Advances in remote patient monitoring include: new peripherals; real-time audio and video for "face-to-face" interaction between clinicians and patients; wireless communication systems that "sort" the vast amount of data collected in order to put it into the context of a patient's condition; portable and ambulatory monitors; web-based access to the patient record; systems that transfer data to an electronic medical record (EMR); and full-service outsourcing that includes a clinician to evaluate data and send a report to the attending physician.

The global advanced patient monitoring market has continued its expansion in both the institutional and home segments of the health market with the United States and many European countries at the forefront of implementation. The advanced patient monitoring market includes products in the following segments: blood management and function monitors, cardiac event and function monitors, neurological event monitors, respiratory function monitors, and other advanced monitors.

Patient monitoring parameters range from basic vital signs to electrocardiograms (ECGs) and implantable cardiac monitors. Patient monitoring peripherals and systems include the following: blood gases, blood pressure (sphygmomanometer), electroencephalography (EEG), fetal heart, glucose meter, pacemaker monitoring, thermometer, transcranial Doppler (TCD), ultrasound, and weight scale, among others.

Advanced Remote Patient Monitoring Systems covers the U.S. market in detail, featuring an entire section of market analysis for patient monitoring in the world's largest healthcare system. The report gives information as well for the following countries, providing market estimates for advanced patient monitoring in Japan, Germany, China, Canada, United Kingdom, France, Italy, Brazil, and Mexico.

There are a huge number of companies offering some form of wireless and remote technologies, patient data processing applications and equipment, and EMR data transfer equipment. Competitors supplying advanced patient monitoring systems to hospitals are large, established healthcare companies, often working in conjunction with information technology (IT) companies on an entire system. The home healthcare and other sectors are much more fragmented and are dominated by privately held companies. In addition, some companies supply innovative products, but only for a small segment of the market; and some companies supply products on a regional basis only. Although there are many participants in the market, a handful of companies continue to make a significant impact on the patient monitoring and technologies market. Some 25 of these companies are profiled in the report.

SOURCE Kalorama Information


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Blood-based biomarkers could revolutionize Alzheimer's diagnosis and treatment